chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Days after shots infant broke out in red, itchy bumps on face/chest. Resolved with Benadryl. No new foods/ soaps/detergents.
After the patient was administered the vaccine, she lost consciousness. The patient was put on her back and she regained consciousness in about a minute. Also applied cold compress to patients face and neck. Stayed with the patient till she felt better to be able to stand and wait after the shot for 30 minutes. She was checked upon periodically to make sure she was doing ok.
Sore arm, body aches, headache began about 17 hours after vaccine.  Continued for the next 24 hours.
Shoulder and neck pain started 20 minutes after shot, excruciating pain by nighttime unable to place any weight on arm, unable to lift arm, any movement caused sharp pain. Weakness, intense pain inability to lift arm fully has continued for 8 days. Went to primary care doctor, steroid pack prescribed, if those do not subside pain, will have to see orthopedist for MRI
This spontaneous report was received from a medical assistant (healthcare worker) refers to multiple unspecified patients of unknown demographics. On an unknown dates, the patients were vaccinated with improperly stored ROTATEQ lot # M031802 with expiration date: 09-NOV-2017; lot # M019691 with expiration date: 02-NOV-2017; lot # M019707 with expiration date: 25-OCT-2017; lot # L044476 with expiration date: 07-SEP-2017; lot # M018957 with expiration date: 22-JUL-2017; (strength and dosage unspecified) via oral route. Temperature excursion details are as follows: temperature of 53.2F for time frame of 4.75 hours (285 minutes). There was no previous temperature excursion. Call was because of a data logger. No adverse effect reported. No product quality complaint involved. No additional information available. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a physician refers to an unspecified patient of unknown age and gender. The physician assistant reported that on 06-JUN-2014 the patient was vaccinated simultaneously with VARIVAX (Merck), injection (strength, dosage, anatomical location, lot # and expiration date not reported) and PROQUAD (Merck), injection (strength, dosage, anatomical location, lot # and expiration date not reported). No adverse effect was reported. No concomitant therapies or medical history were reported. Additional information has been requested.
Headache, nausea, decreased energy, hot to touch at injection site, red and puffy 3x2 area.
Patient complained of headache after receiving Pfizer Covid vaccine. Client was sitting in waiting area post vaccine. EMT responded. Vitals taken at 1528: blood pressure 126/82, pulse 87, respirations 12, oxygen 98. Headache pain 4/10. Per client history of brain injury (encephalopathy) and weakened immune system. Client informed EMT had ate breakfast this morning and hydrated all day. Denied shortness of breath, chest pain, vision changes. Client kept in observation for 30 minutes. EMT reassessed at 1540. Headache still 4/10, same, not worsening or new complaints. Per client felt well to leave. Vitals: blood pressure 118/78, oxygen 99, pulse 80, respirations 12, alert and oriented. Client left facility with a steady gait at 1545.
Rash on upper body, front and back still visible 4 days later. Irritability, soreness at injection site 4 days later. These symptoms were reported to Primary physician Dr. during a routine office visit on 12/08/2016. Onset time is approximate.
Nausea, headache, fatigue, all symptoms lasted approximately 24 hours from onset 1 day post vaccination
Rash that started around left shoulder injection site. Then has spread to face and nasal lacrimal area. Sore throat started 24-48 hours after 1st rash  (the rash on face and lacrimal area at 10 at 24-48 hrs) & possibly strep. I don't think rash rash around vaccine site. Rash not gone yet.
I received the hrpatitis series after being hired in a nursing home. I have also had the booster shots. In 2003 or 2004 I was diagnosed with cataracts. My vision had been getting very poor for a while prior to this date. In June of 2006 I was diagnosed with uveitis.  02/13/2007 Records received from opthomologist for 3 office visits for c/o declining vision. PE reveals vitreous debris bilaterally as well as inflammation.  The right pupil is irregularly shaped.  Synechiae of the right eye noted on 3rd exam.  Inflammation responded well to meds. Impression: Uveitis, cataracts, synechiae OS 2' to Uveitis, Cystoid macular Edema.  Follow-up: The last time you heard from me was this past winter. I had submitted a form about the hepatitis B series and a possible autoimmune reaction to the vaccine. My latest update is that I have had a cataract surgery which didn't much help. I am now on social security disability because I am considered legally blind. I know it is too late for me to be compensated for what I truly believe was a vaccine accident but I hope that the general public is better informed of the possibility than I was.
vaccine was given too early for second booster. patient has not expressed any symptoms or signs yet. I wanted to report this
Headache, fever and body aches. Vancomycin 1000 mg once, methylprednisolone 125 mg once, ketorolac tromethamine 30 mg once.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 79-year-old female patient received BNT162b2 (COMIRNATY), in Mar2020 as dose 2, single (Batch/Lot number: unknown) at the age of 79 years for Covid-19 immunisation. The patient's relevant medical history included: "Heart surgery, triple bypass", start date: 2011, stop date: 2011, notes: Dressler Syndrome diagnosis took 1yr, she had it for 1yr diagnosed 1yr after heart surgery; "Dressler Syndrome" (unspecified if ongoing); "COPD", start date: 2021 (unspecified if ongoing), notes: COPD diagnosed last year; "Reactive airways disease" (unspecified if ongoing), notes: Reactive airways disease diagnosed in the early 1990s; "Sjogren's syndrome", start date: 2020, stop date: 2020, notes: Sjogren's syndrome diagnosed in 2020 maybe; "Hashimoto's disease" (unspecified if ongoing), notes: Hashimoto's disease diagnosed probably in 1980s or 1990s. The patient took concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, NDC/Lot/Expiration: Unknown), administration date: Feb2020, when the patient was 79 years old, for Covid-19 immunization. The following information was reported: LYMPHOEDEMA (non-serious) with onset Apr2020, outcome "not recovered", described as "Lymphedema"; POLYMYALGIA RHEUMATICA (hospitalization, medically significant) with onset Apr2020, outcome "unknown". Therapeutic measures were taken as a result of polymyalgia rheumatica. Clinical information: The caller is a patient. She indicated that she has developed several health problems and she is asking if they could be related to the Pfizer Covid19 vaccine. She developed Polymyalgia rheumatica, lymphedema, She was not specific about when she developed these symptoms, she just mentioned that they appear after getting the 2nd dose of the vaccine. Dressler Syndrome diagnosis took a year to diagnose, she had Dressler Syndrome for a year, diagnosed a year after the heart surgery. Polymyalgia rheumatica: started when the vaccine came out. She had a flare up right after the Covid shot, around the time of the Covid shot. The massive amount of Prednisone has helped. She is in rehab, medications are at the desk. NDC/Lot/Expiration of Prednisone unknown. In the hospital she had three days of Prednisone 500mg IV, along with an IVIG infusion. NDC/Lot/Expiration Unknown for those products. She is now on 40mg Prednisone, at that time her hand opened up but her hand is now retracting again. Lymphedema: started two weeks after Polymyalgia rheumatica. Concomitant medication: normal meds, can't think of any. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Sender's Comments: Linked Report(s): US-PFIZER INC-202200596881 similar report from same reporter.
pt recv vax & 8PM eyes watering, nasal discharge, oral cavity hot w/swelling of gums-gums excessively red in color;mouth uncomfortable & gums swollen x8hr-no dyspnea, no hives, NKA;
Redness and soreness at injection site. Patient instructed to take BENADRYL.
Vaccine given on 09/28/18, returned to office on 09/30/18 with c/o ongoing redness and pain at site, reports low grade temps at 99.0. Temp in office 99.1, upper posterior left arm with 9x5 area of erythema and warmth, ttp, no fluctuance. Treated with cephalexin 500mg TID for 5 days.  Returned to the office on 10/05/18 with c/o increased redness beyond the outlined border. Cephalexin continued for another 5 days.
No BM for 5 days post vaccination. "Infant seemed to have abdominal pain". Stomach gurgled a lot. Fussy and irritable for 24 hrs after vaccination.
Rash, appearance of shingles right side rib area. Did not present until 1 week after symptoms at which time treatment given was Valtrex 1gm po q8 hours 21 tabs given.
Upper left arm became swollen, sore and red at shot site. Later that nite while sleeping I was awakened to pain in left arm. It was swollen more and had red streaks in back of left arm and under left arm. 10/08/2009 I felt like I had the flu and arm was burning and very sore. That PM I ran a low grade temperature of 99.6. 10/09/2009 I still have red streaks running back of arm and under left arm and arm very sore
Patient reports having "PVC's" a few hours after receiving GARDASIL. States that she was having heart palpitations & was given EKG at her mom's job that showed PVC's. Denies dizziness, headache, shortness of breath, difficulty breathing or local reactions.
pt recv vax 14JUL98 & 23JUL98 sx appeared which included extreme fatigue, dizziness, faintness, & sl vision problem;this is now 3 wk from the start of sx & their severity has lessened but they are still existent;
Patient received FLUVIRIN vaccine on 10/5/2015 and came to pharmacy 10/8/2015 4 inch red sore deltoid when vaccine given. Also complaining of itching and warm to touch.
Severe pain legs, feet, back, arms, hands .Low grade temp 99.8 Malaise, weakness.
Kinrix administered to a 4 months-old; Kinrix administered instead of Pentacel; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14th April 2024) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 30th January 2023, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 30th January 2023, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 31-Jan-2023 Reporter's comment: The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. Additional supportive information: The patient received a dose of Kinrix instead of Pentacel at inappropriate age, which led to inappropriate age at vaccine administration and wrong vaccine administered.
This spontaneous case reported by a consumer, describes the occurrence of vomiting (threw-up), nausea (feeling nauseous) and chills in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 15, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 15, 2021, patient experienced vomiting (threw-up). On Mar 16, 2021, patient experienced nausea (feeling nauseous) and chills. On Mar 15, 2021, vomiting (threw-up) resolved. At the time of the report, nausea (feeling nauseous) and chills outcome: unknown. No concomitant medications or treatment information provided.
I have lost hearing in my right ear; the right side of my face was numb; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Batch/lot number number EJ1685, expiration date Mar2021, on 25Dec2020 09:30 at single dose on left arm for Covid-19 vaccination. Medical history and concomitant medications were none. The patient had not received other vaccine in four weeks. The patient had no covid prior vaccination. The patient had no covid tested post vaccination. The patient received her first Covid-19 vaccination on Christmas morning. She worked at a medical center. Within an hour of when she got home, she lost hearing in one ear and also had some numbness on the same side of her face, She was wondering if that was something she should be concerned and she still didn't have hearing in her right ear. Treatment received for the events included Tylenol. The outcome of the events was not resolved.
Fever 102.9C. decreased responsiveness x about 1 hr Morning after shots given. Vomited x 1 also.
Follow up to FAERS18694343: Patient received casirivimab instead of intended COVID vaccine. 48-hr follow up didn't identify AEs. Patient received COVID vaccine December 31
fever to 102+, cranky began 12-24 hrs p/vax; 7 loose BM's, vomiting continue x 48-72 hrs, dec feeding;
Severe numbness in my right arm and tingling like it?s asleep, then sometimes releases and burns then goes back to tingling
Patient was brought into clinic to receive his first covid vaccination with his mother.  Family is going on a cruise and mother needs him to be vaccinated.  Nurse mixed the vaccine with 1.3mls of diluent and injected 0.2mls into left deltoid of the patient.   No adverse effects were reported from parent.
Shingles; Developed rash at injection site within 18 hours; Developed rash at injection site within 18 hours. Spread to upper left arm down to palm within 3 days; some SOB/continued SOB; shooting nerve pains in L arm; This is a spontaneous report from a contactable consumer or other non hcp (patient).    A 75-years-old male patient received second dose of BNT162b2 (BNT162B2, Solution for injection, Batch/Lot number: ER8729), via an unspecified route of administration in left arm on 08Apr2021 at 12:00 (age at vaccination 75 years) as single dose for COVID-19 immunization. The patient's medical history included post-traumatic stress disorder, hypokalaemia, arrhythmia, diabetes, diffuse idiopathic skeletal hyperostosis, drug allergy to penicillin and flu vaccine, all from an unknown date and unknown if ongoing. The patient's concomitant medications included fluoxetine HCL, (POTASSIUM CHLORIDE) and atorvastatin calcium (ATORVASTIN) all taken for an unspecified indications, start and stop dates were not reported. The patient previously received first dose of BNT162b2 (BNT162B2, Solution for injection, Batch/Lot number: EN6204), via an unspecified route of administration in left arm on 18Mar2021 14:00 as single dose for COVID-19 immunisation. The patient experienced shingles, developed rash at injection site within 18 hours developed rash at injection site within 18 hours, spread to upper left arm down to palm within 3 days, some sob/continued sob, shooting nerve pains in L arm on 09Apr2021 at 10:00. The patient stated that, developed rash at injection site within 18 hours, spread to upper left arm down to palm within 3 days with some SOB, shooting nerve pains in L arm. Visited ER on 11Apr2021, dx as shingles, given oral steroid and anti-viral oral med. Visited PCP on 14Apr2021 due to increase of coverage and continued SOB. Steroid injection given, increased dosage of oral steroid. PCP probable dx as Shingles, collected culture. Therapeutic measures taken as a result of the events included emergency room visit on 11Apr2021 and physician office visit on 14Apr2021. Treatment included oral steroid, steroid injection and oral anti-viral medications. The outcome of the events was not recovered at the time of this report.  Follow-up (18Aug2021): Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. On 19-APR-2016 the patient was inadvertently vaccinated with an expired dose of PNEUMOVAX 23 (lot # K007825, expiration date 13-JAN-2016). No adverse effect reported. Additional information has been requested.
Information has been received from a pharmacist referring to a patient of unknown age and gender. On an unknown date the patient was vaccinated with the third dose of RECOMBIVAX HB, 10 mcg/ml (lot #, dose and route unspecified). The pharmacist not4ed the interval between the patient's second and third doses in the RECOMBIVAX HB series was longer (inappropriate schedule of drug administration) than the recommended time period noted the prescribing information; the time period between the administration of the second and third doses of RECOMBIVAX HB was unspecified. No adverse effect was reported. The outcome of the events was unknown. Additional information has been requested.
Developed a fever of about 100.5 about a day after getting the vaccine and the fever has not yet come down even though she was vaccinated over a week ago.
Sky High Fevers; Was actually allergic to the tetanus in this combo vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a male patient who received DTPa (DTPa vaccine) for prophylaxis.   Concurrent medical conditions included tetanus immunization.   On an unknown date, the patient received DTPa vaccine. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced fever and allergy. On an unknown date, the outcome of the fever and allergy were unknown.   It was unknown if the reporter considered the fever and allergy to be related to DTPa vaccine.  Additional information received were as follows: This case was reported by the patient's parent. The age at vaccination was not reported. The reporter reported that their son also ran sky high fevers with DPT. Years later the reporter found out that he was actually allergic to the tetanus in this combo vaccine.
This spontaneous report as received from other health professional (Medical Assistant) refers to multiple unspecified patients of unknown age and gender. Pertinent medical histories, drug reactions or allergies and concomitant therapies were not provided. On unspecified dates since January 2016 (Onset approximated to 2016), the patients were vaccinated with improperly stored doses of GARDASIL 9 injection (batch/lot# K011562 with an expiry date 18-AUG-2017, lot # K026247 with an expiry date 29-JAN-2017) (doses and frequencies unspecified) intramuscularly. No adverse effects were reported. It was reported that vaccines were not discontinued. This is one of the several reports received from the same reporter. Additional information has been requested.
Patient received vaccine that expired 5/10/2022.   Since the dose was given within the 72 days, it did not need to be repeated.
She got her vaccine, she had initial soreness at the site of the injection.  Within 2-3 days she noticed that the pain had spread from the site of injection to the top of her shoulder and down to her elbow.  That has continued.  She has used hot packs on it, she has used cold packs, she has used Diclofenac on it as well.  The only alarming thing is that she cannot raise her hand above her waist, it just hurts.  She can do it, but the pain is terrible.  She is on the Ibuprofen and Tylenol and wonders since taking the pain medication that she is not hurting more.  She has not contacted her doctor as she is impossible to see, and she is scheduling out to April and cannot get an APT.  She is changing to a new PCP on 12/1/23.    She subsequently fell and went to the hospital by ambulance and had x-rays of her shoulder 10/11/23.  She did not have a fracture, but has a repeat x-ray scheduled to make sure that she did not break anything.
TOOK AN UNREFRIGERATED DOSE; This spontaneous case report was received from a consumer (PVX2019-565) on 04-Mar-2019. The report described a female consumer who "took an unrefrigerated dose". The consumer was receiving oral Vivotif (one dose every other day; lot no: 3003239) for typhoid fever prophylaxis.  It was reported that the consumer took the first dose of Vivotif that was unrefrigerated for around 17 to 18 hours at 68 degree Fahrenheit.  The action taken with Vivotif with respect to the event "took an unrefrigerated dose" was not applicable.  The clinical outcome of the event "took an unrefrigerated dose" was unknown.  Company's Comment: The causality of the event "took an unrefrigerated dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took an unrefrigerated dose" was considered as not applicable.
Patient concerned about enlarged lymph nodes, headache, tenderness & itching of the site as well as worry over appearance of the site. Erythema measured 3 cm x 3 cm  & eschar 1.5 cm x 0.75 cm. Tender surrounding deltoid without drainage building or streaking.
This spontaneous report as received from an office manager refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 (lot# L037554, expiration date: 25-DEC-2017; lot# L044475, expiration date: 31-MAY-2017; reported lot# L048337, expiration date: 08-MAY-2017; lot# L048237, expiration date: 08-MAY-2017; lot# L016428, expiration date: 30-JUL-2016, and lot# L014415, expiration date: 25-JUL-2017) (doses and route of administration were not reported). There was no adverse effect reported. This is one of several reports from the same reporter. Additional information has been requested.
Severe muscle and joint pain and stiffness throughout body.  Taking ibuprofen and Tylenol.
Patient sat for over 10 minutes in chair before getting up to go shop with his parents in the store. Mom came back to pharmacy saying her son had fainted.  I ran up to the aisle and the child way lying on the floor with his father. He was alert with eyes open and talking.  We called EMS and they took vitals and said everything checked out normal and thought it was a catalyst reaction. They released patient to go home with parents. They shopped in store and then left.
About 15 minutes after injection, patient began experiencing itching on her head which progressed downward over the rest of her body.  after about 20 minutes, she developed hives on her arms and legs.  Reaction resolved within 24 hours without intervention.
Fever, spiked at 101.4  F, and chills and malaise Elevated pulse (88 bpm, up from 76 normally) Unable to measure BP at home Nausea (could not eat) Myalgias that lasted 3-4 days throughout entire body, including distal extremities (fingers, toes) The muscle pain was unlike anything I have ever experienced (or at least remember). This was a scary set of symptoms while it lasted, and I considered an Urgent Care visit. The reaction started about 45 hours after receiving the vaccination, reached its peak 10 hours later, and gradually abated after that, leaving occasional twinges of muscle pain at time of report.